ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Sanford-Burnham Teams With Mayo

by Lisa M. Jarvis
March 18, 2013 | APPEARED IN VOLUME 91, ISSUE 11

After a successful yearlong pilot phase, Sanford-Burnham Medical Research Institute and the Mayo Clinic have expanded a collaboration to discover new medicines. The partners plan to build a pipeline of new drugs by combining Mayo’s clinically relevant targets with Sanford-Burnham’s discovery platform. Mayo scientists will team with researchers at Sanford-Burnham’s Conrad Prebys Center for Chemical Genomics, which has expertise in assay development, high-throughput screening, and lead identification.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment